Skip to main content

Table 1 Patients’ characteristics

From: The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

  Total FSS (N%) Radical surgery (N%)
Total 92 54 (58.7) 38 (41.3)
FIGO stage
 IA 35 (38) 31 (57.4) 4 (10.5)
 IB 9 (9.8) 3 (5.6) 6 (15.8)
 IC 18 (19.6) 8 (14.8) 10 (26.3)
 II 8 (8.7) 1 (1.9) 7 (18.4))
 III 22 (23.9) 11 (20.4) 11 (28.9)
Diameter
 < 10 cm 50 (54.3) 27 (50.0) 23 (60.5)
 ≥ 10 cm 42 (45.7) 27 (50.0) 15 (39.5)
Histology
 Serous 46 (50) 26 (48.1) 20 (52.6)
 Mucinous 38 (41.3) 25 (46.3) 13 (34.2)
 Endometrioid 7 (7.6) 2 (3.7) 5 (13.2)
 Serous and mucinous 1 (1.1) 1 (1.9) 0 (0)
Lesion lateral
 Left 44 (47.8) 26 (48.1) 18 (47.4)
 Right 29 (31.5) 17 (31.5) 12 (31.6)
 Bilateral 19 (20.7) 11 (20.4) 8 (21.1)
Rupture
 Yes 17 (18.5) 10 (18.5) 7 (18.4)
 No 75 (81.5) 44 (81.5) 31 (81.6)
Micropapillary
 Yes 16 (17.4) 11 (20.4) 5 (13.2)
 No 76 (82.6) 43 (79.6) 33 (86.8)
Microinvasion
 Yes 7 (7.6) 5 (9.3) 2 (5.3)
 No 85 (92.4) 49 (90.7) 36 (94.7)
Invasive implants
 Yes 4 (4.3) 2 (3.7) 2 (5.3)
 No 88 (95.7) 52 (96.3) 36 (94.7)
Pelvic lymph node
 Positive 10 (10.9) 6 (11.1) 4 (10.5)
 Negative 82 (89.1) 48 (88.9) 34 (89.5)
Para-aortic lymph node
 Positive 3 (3.3) 2 (3.7) 1 (2.6)
 Negative 89 (96.7) 52 (96.3) 37 (97.4)
Lymphadenectomy
 Yes 55 (59.8) 26 (48.1) 29 (76.3)
 No 37 (40.2) 28 (51.9) 9 (23.7)
Surgery approach
 Laparoscopy 7 (7.6) 5 (9.3) 2 (5.3)
 Laparotomy 85 (92.4) 49 (90.7) 36 (94.7)
Adjuvant chemotherapy
 Yes 10 (10.9) 4 (7.4) 6 (15.8)
 No 82 (89.1) 50 (92.6) 32 (84.2)
Staging surgery
 Yes 87 (94.6) 51 (94.4) 36 (94.7)
 No 5 (5.4) 3 (5.6) 2 (5.3)
Appendectomy
 Yes 8 (8.7) 5 (9.3) 3 (7.9)
 No 84 (91.3) 49 (90.7) 35 (92.1)
Recurrence
 Yes 22 (23.9) 19 (35.2) 3 (7.9)
 No 70 (76.1) 35 (64.8) 35 (92.1)
Death 0 0 0